Row | Study Title | Conditions | Interventions | Detail |
---|---|---|---|---|
471 | Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia | Leukoplakia, Oral |
Drug:Nivolumab |
detail |
472 | Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy | Congenital Myotonic Dystrophy |
Drug:Tideglusib Drug:Placebo |
detail |
473 | Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis | Systemic Sclerosis|Small Intestinal Bacterial Overgrowth |
Drug:Saccharomyces Boulardii Oral Tablet Drug:Metronidazole |
detail |
474 | Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp | Postoperative Pain |
Combination Product:Silver nanoparticle/Calcium hydroxide Drug:Silver Nanoparticles in gel form Drug:Calcium Hydroxide Intracanal medication |
detail |
475 | Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar | Burns|Hypertrophic Scar |
Procedure:Luminis ultrapulse fractional ablative carbon dioxide laser Procedure:0.5mm punch biopsy |
detail |
476 | Fracture Gap After Herbert Screw Insertion by 3d Stents Vs Titanium Plate(Minimally Displaced Mandibular Angle Fracture) | Minimally Displaced Mandibular Angle Fracture |
Procedure:3D stent in Herbert screw insertion vs titanium plate |
detail |
478 | Homoarginine Supplementation in Patients After Stroke | Deficiency; Diet |
Dietary Supplement:125 mg L-homoarginine Other:placebo |
detail |
479 | Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease | Disc Degeneration |
Drug:MSC Treatment group 1 (low dose) Drug:MSC Treatment group 2 (high dose) Other:Healthy Control (no treatment) |
detail |
480 | Managing Diabetes to Gain Opportunities for a More Active Life | Diabetes Mellitus, Type 2 |
Behavioral:My Diabetes Goal Survey and Optional Care Management |
detail |
481 | Assessment of Sleep by WHOOP in Ambulatory Subjects | Sleep Quality |
Device:WHOOP Strap 2.0 |
detail |